TS03 Inc Trust Units TSTIF

RE:RE:RE:RE:RE:RE:Tremendous news

[lematou22]

Again, the share prices do not move significantly because there's not much new in the press release.  Furthermore, there is something that has been weighting the price for more than 6 weeks now, if not more. 

One has to go back to last spring when the FDA held a two-day symposium over the problems with the duedonoscopes.  One has to remember how many participants suggested that the community forget about  disinfection and move on to sterilization eventhough at the time, and still up today in the US, the only possibility was to move to ETO machines.  One can also recall that , at the time, Rumble was enthusiastic.  Many will remember his "game changing" comment.

Fastforward to early this year when Olympus announced it had gained clearance from the FDA for a revised model of it's duedonoscope and some new cleaning procedures.  Moving forward again, this week, Olympus also gained clearance for revised cleaning procedures that would allow it to continue selling it's duedonoscope.

Those two events are significant in that, for the foreseable future, it is unlikely that the FDA will require the sterilization of the duedonoscopes.  The problems with these scopes are not "game changing" anymore.  This is the news that is weighting the market.

It doen't mean Tso3 doen't have a promissing future.  The machine has a whole lot of advantages over the competition.  The company will only have to work harder especially, when cleared in the US, to convince hospitals to go the sterilization way when dealing with the nasty scopes.